FDA Adverse Event Reporting System

A popular class of weight loss and diabetes drugs looks to be safer than feared, at least so far. This week, the Food and Drug Administration announced it hasn’t found compelling evidence that Wegovy, Ozempic, and other GLP-1 drugs can cause suicidal thoughts or behaviors—a concern that first emerged last year. The FDA hasn’t definitively ruled out a possible connection just yet, however, and it is still conducting further investigation into the matter.Would Peter Capaldi Return to Doctor Who?In summer 2023, health…

Wegovy and similar weight loss drugs may cause more side effects than currently recognized. The Food and Drug Administration is now looking into whether these new generation obesity drugs can trigger hair loss, suicide ideation, and food aspiration, based on adverse event reports linked to their use. These reports are only intended to be a potential warning signal and do not prove causation, but the FDA could take further regulatory action should their investigation bear fruit, such as modifying the drugs’ labeling.Let’s…